Spectranetics Corp (SPNC) Tops Q3 EPS by 2c; Boosts FY11 Revs Outlook
Tweet
Share
E-mailGet Alerts SPNC Hot Sheet
Price: $38.45 --0%
Financial Fact:
Operating income (loss): -9.86M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income (loss): -9.86M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Spectranetics Corp (NASDAQ: SPNC) reported Q3 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $32.1 million versus the consensus estimate of $30.83 million.
Sees FY2011 revenue of $126-$127 million, versus prior guidance of $122.5-$126.5 million and the consensus of $125.27 million.
Sees FY2011 revenue of $126-$127 million, versus prior guidance of $122.5-$126.5 million and the consensus of $125.27 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
